News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
50,225 Results
Type
Article (3878)
Company Profile (28)
Press Release (46319)
Section
Business (15363)
Career Advice (69)
Deals (2019)
Drug Delivery (9)
Drug Development (4756)
Employer Resources (3)
FDA (815)
Job Trends (1409)
News (22752)
Policy (1767)
Tag
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Pharm Country Digital (1)
2026 BioCapital Standard (1)
Academia (447)
Allergies (3)
Alliances (5826)
ALS (8)
Alzheimer's disease (65)
Antibody-drug conjugate (ADC) (4)
Approvals (814)
Artificial intelligence (31)
Autoimmune disease (1)
Automation (6)
Bankruptcy (19)
Best Places to Work (1262)
BIOSECURE Act (12)
Biosimilars (1)
Biotechnology (25)
Bladder cancer (10)
Brain cancer (3)
Breast cancer (71)
Cancer (287)
Cardiovascular disease (9)
Career advice (69)
Career pathing (2)
CAR-T (8)
Cell therapy (44)
Cervical cancer (1)
Clinical research (3510)
Collaboration (116)
Compensation (30)
Complete response letters (1)
COVID-19 (225)
CRISPR (17)
C-suite (13)
Cystic fibrosis (10)
Data (200)
Diabetes (13)
Diagnostics (1441)
Digital health (2)
Diversity, equity & inclusion (1)
Drug discovery (13)
Drug pricing (2)
Duchenne muscular dystrophy (5)
Earnings (4101)
Editorial (1)
Employer branding (1)
Employer resources (3)
Events (7350)
Executive appointments (64)
FDA (879)
Featured Employer (7)
Funding (51)
Gene editing (47)
Generative AI (2)
Gene therapy (43)
GLP-1 (37)
Government (319)
Guidances (6)
Healthcare (1393)
Huntington's disease (1)
Immunology and inflammation (3)
Infectious disease (235)
Inflammatory bowel disease (11)
Influenza (5)
Intellectual property (9)
Interviews (8)
IPO (918)
Job creations (188)
Job search strategy (65)
Kidney cancer (1)
Layoffs (24)
Legal (328)
Liver cancer (7)
Lung cancer (43)
Lymphoma (9)
Management (1)
Manufacturing (26)
MASH (2)
Medical device (425)
Medtech (426)
Mergers & acquisitions (1130)
Metabolic disorders (27)
NASH (1)
Neurodegenerative disease (6)
Neuropsychiatric disorders (2)
Neuroscience (97)
NextGen: Class of 2025 (418)
Non-profit (326)
Northern California (289)
Now hiring (2)
Obesity (11)
Opinion (30)
Ovarian cancer (2)
Pain (3)
Pancreatic cancer (11)
Parkinson's disease (11)
Partnered (1)
Patents (11)
Patient recruitment (3)
Peanut (1)
People (4696)
Pharmaceutical (3)
Phase I (1354)
Phase II (1632)
Phase III (1185)
Pipeline (69)
Policy (14)
Postmarket research (80)
Preclinical (713)
Press Release (22)
Prostate cancer (12)
Radiopharmaceuticals (6)
Rare diseases (45)
Real estate (367)
Regulatory (1251)
Reports (3)
Research institute (525)
Resumes & cover letters (3)
RSV (1)
Schizophrenia (3)
Series A (11)
Series B (6)
Sickle cell disease (15)
Southern California (229)
Spinal muscular atrophy (2)
Sponsored (2)
Startups (377)
Supply chain (5)
United States (1887)
Vaccines (22)
Venture capitalists (2)
Webinars (1)
Weight loss (6)
Date
Today (5)
Last 7 days (43)
Last 30 days (174)
Last 365 days (3031)
2025 (617)
2024 (3209)
2023 (3763)
2022 (4964)
2021 (5070)
2020 (4343)
2019 (3329)
2018 (2505)
2017 (2824)
2016 (2732)
2015 (2831)
2014 (1825)
2013 (1554)
2012 (1554)
2011 (1585)
2010 (1410)
Location
Africa (64)
Alabama (8)
Alaska (1)
Arizona (22)
Asia (2506)
Australia (385)
California (627)
Canada (86)
China (42)
Colorado (24)
Connecticut (47)
Delaware (9)
Europe (6425)
Florida (74)
Georgia (4)
Idaho (1)
Illinois (25)
India (3)
Indiana (13)
Iowa (3)
Japan (17)
Kansas (2)
Kentucky (1)
Louisiana (1)
Maine (3)
Maryland (62)
Massachusetts (364)
Michigan (14)
Minnesota (20)
Missouri (6)
Montana (2)
Nebraska (5)
Nevada (5)
New Hampshire (2)
New Jersey (119)
New Mexico (11)
New York (83)
North Carolina (128)
North Dakota (6)
Northern California (289)
Ohio (31)
Oregon (1)
Pennsylvania (46)
Rhode Island (3)
South America (64)
South Carolina (2)
Southern California (229)
Tennessee (3)
Texas (92)
Utah (23)
Virginia (7)
Washington D.C. (4)
Washington State (34)
Wisconsin (9)
50,225 Results for "ers genomics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ERS Genomics launches ‘Express License’ platform to democratise access to CRISPR/Cas9
January 14, 2025
·
3 min read
Business
ERS Genomics Appoints John E Milad as Chief Executive Officer
ERS Genomics Limited, the CRISPR licensing company, announced the appointment of John E Milad as CEO, with immediate effect.
May 13, 2024
·
3 min read
ERS Genomics and IRBM Sign CRISPR/Cas9 License Agreement
ERS Genomics Limited, the CRISPR licensing Company, and IRBM, a leader in the field of drug discovery, announced a non-exclusive CRISPR/Cas9 license agreement.
May 20, 2024
·
2 min read
Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement
Ricoh Company, Ltd. announced a non-exclusive licensing agreement in the USA and Japan with ERS Genomics Limited for access to the foundational CRISPR/Cas9 genome editing technology patents managed by ERS Genomics.
March 13, 2024
·
2 min read
Press Releases
ERS Genomics and Université de Montréal Sign CRISPR/Cas9 License Agreement
October 1, 2024
·
2 min read
ERS Genomics and StemSight Sign CRISPR/Cas9 License Agreement
ERS Genomics Limited, the CRISPR licensing Company, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr Emmanuelle Charpentier, and StemSight Oy, a biotechnology company developing stem cell based therapies for corneal blindness, announced a non-exclusive CRISPR/Cas9 license agreement.
January 17, 2024
·
2 min read
Press Releases
Moss Genomics Announces Genomics Business Update, Integrating Blockchain for Genomic Security and Transparency
February 25, 2025
·
7 min read
Press Releases
Ecotone Achieves Breakthrough in Human Genome Understanding with Novel AI Technology
AI-Powered Genomic Mapping Could Revolutionize Treatment of Rare Genetic Diseases
January 16, 2025
·
1 min read
Press Releases
Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England
March 21, 2025
·
3 min read
Press Releases
CD Genomics Launches Innovative NGS-BSP to Enhance Genomic Understanding
March 27, 2025
·
1 min read
1 of 5,023
Next
